Asah1 gene plays key role in preventing progression of nonalcoholic fatty liver disease

FHS
March 7, 2025
2:29 am

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by regulating hepatic lipid homeostasis and cellular maintenance processes.

FDA Turns Down TransCon PTH; Black Market Hormones; Pandemic Thyroid Tumors

Denmark’s Ascendis Pharma announced that the FDA declined to approve the company’s new drug application for the hypoparathyroidism drug palopegteriparatide (TransCon PTH) due to manufacturing

May 3, 2023

Should Normal Range of Albumin Be Redefined for Cardiovascular Health?

Growing evidence points to kidney health as a major contributor to cardiovascular health, with the implication that there should be more testing and treatment for

December 20, 2023

Cybin Announces Renewed At-The-Market Equity Program of up to US$35 Million | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.